Analysis of Automated Breast Ultrasound System Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
The global automated breast ultrasound system market is anticipated to propel at a CAGR of 9.7% from 2023 to 2033. The market is valued at US$ 1.7 billion in 2023 and is predicted to reach US$ 4.3 billion by 2033-end.
The amount of milk in the breast is determined using automated breast volume scanners. Due to the use of ultrasound technology, the results are precise. The transparent screen makes it simple for the user to see milk ducts, galaxies, and lobules. By using a transducer and probe combination to examine the fatty tissues located around the breasts, these scanners are helping in determining whether a patient is pregnant or not.
Ultrasound is utilized as a diagnostic tool in many different areas of the medical field to direct procedures, identify anomalies, assess pregnancies, and inspect internal organs. Ultrasound has a wider range of applications in the medical field thanks to technological advancements in ultrasound machines. The quality control of new ultrasonic technology has made it possible to more precisely and reliably determine the existence of breast cancer by detecting small masses in women's dense breast tissues.
Automated breast ultrasound systems' ability to interpret breast cancer with more accuracy and shorter scanning times are expected to drive market expansion. The market for automated breast ultrasound systems is stimulated by the increasing incidence of breast cancer globally and growing awareness efforts about breast cancer diagnostics by government organizations. A major increase in demand for ABUS is attributed to the system's improved accuracy when combined with mammography to provide a useful screening tool for women with dense breasts.
Established players may see the potential for expansion as a result of improved product standards and the transition from handheld to automated systems. The market is expected to grow throughout the forecast period as a result of the rising trend of early diagnosis as preventative care.
New developments in breast cancer detection equipment are driving the global demand for automated breast ultrasound systems. Companies are offering advanced technologies to improve cancer screening in patients with thick breasts, increasing the effectiveness of breast cancer detection. Innovations in automated breast ultrasound systems are anticipated to address shortcomings in conventional systems. These technological advancements will raise consumer acceptance of enhanced cancer imaging, promoting industry expansion.
A majority of diagnostic centers are moving away from radiography and MRI procedures and towards automated breast ultrasound systems, which bodes well for market expansion. The growing demand for reliable identification of breast lesions, particularly in the early stages of cancer, and the shortage of radiologists with the necessary expertise to utilize conventional ultrasound equipment are encouraging major manufacturing companies to develop accurate, automated diagnosis methods.
Automated Breast Ultrasound System Market Size (2023)
US$ 1.7 Billion
Projected Market Value (2033)
US$ 4.3 Billion
Global Market Growth Rate (2023 to 2033)
Market Share of Automated Breast Volume Scanners
Key Companies Profiled
Don't Need a Global Report?
Save 40% on Country & Region specific reports
“Increasing Need for Advanced Imaging Technologies for Cancer Detection & Diagnosis”
According to the World Health Organization (WHO), breast cancer starts in the living cells of the ducts (85%) or lobules (15%) in the glandular tissue of the breast. In terms of lost disability-adjusted life years, breast cancer is the type of cancer that affects women the most all over the world.
Women in their middle years and older tend to develop breast cancer more commonly. Breast cancer is typically diagnosed in women 62 years of age or older. Breast cancer diagnoses in women under the age of 45 are extremely rare.
The rise in breast cancer patients is the main factor driving the market for automated breast ultrasonography systems worldwide. Breast cancer is one of the most common cancers in women and the second greatest cause of death globally. Rising sedentary lifestyle trends have also contributed to an increase in cancer patients.
Many women are becoming aware of the value of early identification of breast cancer through screening procedures such as mammography and automated ultrasound systems. In addition, the growing need for advanced technologies for cancer detection and diagnosis is anticipated to open up the potential for market participants over the coming years.
The adoption of specialist diagnostic instruments across diagnostic centers is aided by an increase in healthcare spending. These facilities provide patients with breast cancer with improved medical care by utilizing specialized diagnostic imaging equipment. The implementation of breast cancer detection equipment throughout these facilities will be driven by the growing patient choice for specialized diagnostic options.
“Shortage of Radiologists and High Cost of Ultrasound Systems”
The market for automated breast ultrasound systems is restrained by factors such as the shortage of radiologists, and the need for existing radiologists to complete ultrasound imaging training. Key factors limiting the global market for automated breast ultrasound systems include economic instability and a lack of investment from major players in the development of new equipment.
According to the latest pricing trends, the high cost of ultrasound systems in contrast to conventional cancer screening techniques is hampering market expansion. Due to severe legislation, the local supply of automated breast ultrasound imaging techniques has been limited in several countries, which is disrupting supply chain management. Despite being quick and efficient in finding cancer, ultrasonography is also prone to false-positive biopsies, which is expected to restrain market growth.
“Rising Investments by Public & Commercial Sectors to Raise Awareness of Breast Cancer in North America”
North America accounts for 50% share of the global ABUS market due to the existence of numerous major competitors and the high prevalence of breast cancer. Technological advancements in automated breast ultrasound systems to find breast cancer in breast tissue with dense cellularity are the elements driving market value.
Rising investments by both the public and commercial sectors to raise awareness of breast cancer early detection and treatment are supporting market expansion.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
“Growing Demand for Advanced Breast Imaging Technologies”
The market in the United States is projected to expand owing to the increase in government programs to educate women about breast cancer, the growing demand for advanced breast imaging technologies, and the surging need for screening owing to high cancer awareness.
“Favorable Insurance Policies Stimulating Market Value”
The automated breast ultrasound system market in Germany is primarily driven by rapid urbanization, the presence of an established healthcare infrastructure, advantageous insurance policies, rising consumer healthcare spending, and escalating need for advanced non-invasive breast imaging techniques.
Market participants in Germany are attempting to optimize the automated breast ultrasound market in compliance with stringent government rules and standards. The development of advanced cancer diagnostic facilities will have a beneficial impact on the market demand for automated breast ultrasound systems.
“Increase in Hospitals & Imaging Diagnostic Centers for Cancer Patients”
Japan is predicted to present huge potential prospects for the market due to population growth and partnerships between hospitals and commercial companies. The market in Japan is driven by high spending on R&D to update technologies for more accurate findings, growing medical tourism, and an increase in hospitals and imaging diagnostic centers for cancer patients.
“Improved Diagnostic Accuracy Driving Demand for Automated Breast Volume Scanners”
Based on product, the market is divided into automated breast ultrasound systems and automated breast volume scanners. Automated breast volume scanners account for 50% share of the global market.
Automated breast volume scanners precisely analyze lactiferous ducts and evaluate the volumetric images of the breast using high-frequency ultrasound light. Increasing patient preferences for minimally invasive diagnostic techniques driving the demand for automated breast volume scanners.
Real-time imaging support is available to direct these scanners. Other benefits of automated breast volume scanners include rapid and painless treatments and improved diagnostic accuracy that facilitates early detection of breast cancer.
“Growing Awareness of Routine Breast Cancer Screening Tests in Hospitals”
The market is divided into hospitals and diagnostic centers based on end user. Automated breast ultrasound system deployment is gaining traction in hospitals to suit the patient's diagnostic needs. Increased use of cancer screening tests among young and middle-aged women will be the primary factor driving the demand for ABUS in these healthcare settings. Because pregnant women cannot undergo mammography owing to the radiation risk, hospitals are installing automated breast ultrasound systems to offer safer diagnostic options.
Breast cancer surgery entails operating to remove the tumor, which is an essential component of the disease's treatment. Breast cancer surgery is a treatment option for breast cancer that can be used alone or in combination with other treatments such as radiation therapy, hormone therapy, targeted therapy, and chemotherapy that are delivered in a hospital setting under the supervision of a qualified physician.
Demand for automated breast ultrasound systems in hospitals will increase due to the expanding patient population, quick availability of medical tools and technology, and the presence of qualified staff.
Traditional handheld ultrasound systems have drawbacks when used for breast cancer screening, such as a prolonged screening duration and difficulty using the system. Leading companies are focusing on creating new automated breast ultrasound systems to get over the limitations of conventional devices. Key market players are concentrating on combining automated breast ultrasound systems with full-field digital mammography (FFDM) to create a single platform that can provide higher-quality images.
Top market participants are emphasizing installing automated breast ultrasound systems in medical facilities & diagnostic centers following safety regulations to reduce the environmental impact and increase their worldwide presence. In addition to obtaining regulatory certification for their products, they are also aiming to improve the accuracy of automated breast ultrasound systems for a quicker assessment of cancer screening.
For instance :
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesBuy Now
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
- Related Reports -
The global automated breast ultrasound system market is valued at US$ 1.7 billion in 2023.
Demand for automated breast ultrasound systems is expected to rise at a CAGR of 9.7% through 2033.
Worldwide sales of automated breast ultrasound systems are estimated to reach US$ 4.3 billion by 2033.
Growing prevalence of breast cancer and rising technological advancements in automated breast ultrasound systems are driving market growth.
North America accounts for 50% share of the global market.
Need An Exclusive Report For Your Unique Requirement?